Concerns mounting over controversial contraceptive plan

The Korea Food and Drug Administration (KFDA)’s plan to reclassify contraception pills has finally foundered after some interest groups’ vehement opposition to the changes.

Despite a series of public hearings on the issue, the health authorities stepped back, citing a need to canvass public opinion for three more years in the face of an unbridgeable gulf on all sides.

The announcement wa...